IMPALA Consortium Website: https://impala-consortium.org/

The Inter coMPany quALity Analytics (IMPALA) Consortium’s mission is to transform the Biopharmaceutical Clinical Quality Assurance process in the Good Clinical Practice and Good Pharmacovigilance Practice areas, by using advanced analytics and promoting the adoption of this new approach and associated methodologies by key industry stakeholders (e.g. pharma quality professionals, Health Authorities) to assure safe use, therefore building patient trust, accelerating approvals and ultimately benefiting patients globally. The IMPALA Consortium will provide the strategic focus for working across the Biopharmaceutical ecosystem to develop and gain industry-wide consensus for the adoption of improved QA using advanced analytics and best practices to be used across the industry.

Program News

IMPALA Consortium at DIA 2024 (Press Release)
Date: 26 Jun 2024

New IMPALA Work Product: Data Analytics for Quality Assurance in Pharmaceutical Development Framework (Press Release)
Date: 27 Jun 2024

IMPALA Clinical Trial Anomaly Spotter Webinar (Press Release)
Date: 06 May 2024

{simaerep} v0.5.0 now available (Press Release)
Date: 18 Apr 2024

IMPALA’s Newest Publication: An Open-Source R Package for Detection of Adverse Events Under-Reporting in Clinical Trials: Implementation and Validation (Press Release)
Date: 12 Apr 2024

An Open-Source R Package for Detection of Adverse Events Under-Reporting in Clinical Trials: Implementation and Validation by the IMPALA (Inter coMPany quALity Analytics) Consortium (Media Coverage)
Date: 02 Apr 2024

Clinical Trial Anomaly Spotter (CTAS) Package Now Available (Media Coverage)
Date: January 22, 2024

On November 9, 2023, IMPALA hosted a webinar on Embedding an Open Source Package into Analytics-Based Audits. During this presentation, Bjoern Koneswarakantha and Lisa Bennett of Roche discussed IMPALA’s Clinical Safety Reporting R package. ()
Date: 9 Nov 2023

RQA features a session from IMPALA Consortium titled “Overview of IMPALA Industry Group and its impact on modernizing GCP/PV Quality.” (Press Release)
Date: 01 Apr 2023

IMPALA welcomes new members in an article written by ISTO. (Press Release)
Date: 01 Apr 2023

IMPALA Consortium Welcome New Members (Press Release)
Date: 26 May 2023

RQA Quality Conversation Session (Press Release)
Date: 10 May 2023

IEEE Spectrum Feature: Big Data Could Accelerate Drug Approvals (Press Release)
Date: 15 Feb 2023

RQA Workshop on Data Analytics Write-Up Now Available (Press Release)
Date: 29 Nov 2022

Clinical Safety Reporting Work Product Stream (Press Release)
Date: 15 Nov 2022

Official Launch of Inter Company Quality Analytics (IMPALA) Consortium (Press Release)
Date: 03 Nov 2022